Developing the Next Generation of Myeloid Cell Targeted Therapies: Opportunities & Challenges
Time: 1:30 pm
day: Conference Day One
Details:
- Novel strategies for myeloid cell-based therapies – how adoption of synthetic biology approaches can develop the next generation of genetically modified effector cells
- Strategies for therapeutic targeting of myeloid cells in situ
- Characterisation strategies and biomarkers for achieving an optimum phenotype of engineered myeloid cells to achieve a successful allogeneic therapy
